Braunwald: Vorapaxar Problem Based on Intracranial Bleeding in Patients with History of Stroke

A key detail has now emerged about the problems encountered with vorapaxar, Merck's thrombin receptor antagonist that suffered a large setback last we...

To continue reading, please log in to the right or request an invitation.